+105.2%
GSK vs KIM
+63.6%
+41.6%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | KIM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | +0.4% | +0.2% | +0.5% |
| 7D | +1.1% | +0.1% | +1.0% | +1.1% |
| 30D | +6.3% | +14.1% | -7.8% | +4.0% |
| 3M | +1.8% | +6.0% | -4.2% | +0.8% |
| 6M | +1.7% | +13.2% | -11.6% | -0.4% |
| YTD | +6.5% | +30.4% | -23.8% | +2.0% |
| 1Y | +9.5% | +31.0% | -21.5% | +4.7% |
| 3Y | +65.3% | +67.6% | -2.3% | +51.2% |
| 5Y | +43.7% | +35.8% | +8.0% | +34.5% |
| All | +105.2% | +63.6% | +41.6% | +80.1% |
Cumulative growth
Daily Returns
Daily percentage return beside KIM.
Daily Out/Under-Performance
Portfolio return minus KIM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × KIM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded KIM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling